The "China Precision Medicine " program is still in a retreat stage.
The "60 billion" China Precision Medical "Program News is not true." Recently, the "Financial Weekly" reporter asked the Director of the Department of Biomedical Science and Technology of the Ministry of Science and Technology Zhang Zhaofeng to find out.
According to academics, the so-called "precise medical" is a new medical concept and medical model based on individualized medical treatment, with the rapid advancement of genome sequencing technology and the cross-application of biological information and big data science. The essence is to accurately find the cause of the disease and the therapeutic target through the genomics, proteomics and other omics technologies and medical frontier technologies, and finally achieve the purpose of personalized and precise diagnosis and treatment.
Earlier this year, US President Barack Obama launched a "precise medicine" large-scale medical research program to overcome disease problems such as cancer, and will invest $215 million in the fiscal year 2016. For a time, precision medicine has received much attention. Subsequently, Wang Yongjun, deputy dean of Beijing Tiantan Hospital, revealed at an academic conference that China's precision medical plan will start in the second half of 2015 or next year, and the Ministry of Science and Technology decided to invest 60 billion yuan by 2030. As soon as this statement came out, it immediately ignited the circle of public opinion.
Although the news is not true, whether China will formulate a "precise medical" plan suitable for the national conditions in the future remains to be seen.
“The national level is discussing how to implement precision medicine in China, but it is still in a stage of retreat.†Cheng Jing, an academician of the Chinese Academy of Engineering and president of Boao Bio-Group Co., Ltd., told reporters that it is necessary to understand that the US has launched this major plan but only invested With a driving force of $215 million, we should have our own thinking and not blindly follow.
According to the 2015 annual statistical report released by the National Cancer Registry, the incidence of cancer and mortality in China has increased significantly over the past decade, with 6.4 cancer cases per minute, of which more than 60%-80% are It was already in the middle and late stages of discovery.
On April 10, the National Health and Family Planning Commission announced the first batch of clinical application units for tumor gene sequencing . In the eyes of the industry, this shows the government's determination to promote the development of precision medicine.
It is understood that the current research on precision medicine in China mainly focuses on two aspects. The first is clinical epidemiological research based on big data and comprehensive medicine. For example, to establish a database of healthy human and disease groups, through the integrated analysis of big data, to obtain the pathogenic factors. The second is the study of the transformation of research results in the fields of physics, information science, medicine and life science into clinical practical techniques.
"Integration of production, education and research is of great significance for disease prevention and control," said Han Demin, academician of the Chinese Academy of Engineering and president of Beijing Tongren Hospital.
Cheng Jing also believes that the current implementation of a series of plans around "precise medical care" is crucial for the development of related industries. The American Human Genome Project has spawned a huge industry. If our "precise medical care" in the future is simply to buy foreign instruments and reagents to do it, then when the industry of others goes up a step, we will have nothing.
From an industrial point of view, manufacturing a sequencer is very pragmatic. According to Cheng Jing, as the first pilot unit for clinical application of tumor gene sequencing, Boao Bio-Group Co., Ltd. has installed four fully automatic equipments for sample preparation, which will be officially released during the year.
In this regard, the government level is also planning. Qin Huaijin, director of the Science and Education Department of the National Health Planning Commission, pointed out at the "Precision Medicine Forum" on April 21 that the "precise medical" research and plan with Chinese characteristics, the goal and task is to solve the health problems of the Chinese people (603883, shares) At the same time, we must promote the development of the entire biomedical industry. China will not and cannot miss the major medical changes affecting all mankind.
Sensor And Emergency LED Dustproof Fitting
Sensor And Emergency Led Dustproof Fitting,Sensor And Emergency LED Dustproof Light Fitting
Ningbo Wellway Optoelectronic Technology Co.,Ltd , https://www.wellwayopto.com